J. Schmitz, M. Kuroda, and S. Santra, Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes, Science, vol.283, issue.5403, pp.857-860, 1999.
DOI : 10.1126/science.283.5403.857

J. Kahn and B. Walker, Acute Human Immunodeficiency Virus Type 1 Infection, New England Journal of Medicine, vol.339, issue.1, pp.33-39, 1998.
DOI : 10.1056/NEJM199807023390107

S. Deeks and B. Walker, Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy, Immunity, vol.27, issue.3, pp.406-416, 2007.
DOI : 10.1016/j.immuni.2007.08.010

A. Saez-cirion, C. Lacabaratz, and O. Lambotte, HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proceedings of the National Academy of Sciences, vol.1, issue.4, pp.6776-6781, 2007.
DOI : 10.1128/JVI.77.4.2550-2558.2003

URL : https://hal.archives-ouvertes.fr/pasteur-00142658

S. Bauer, V. Groh, and J. Wu, Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA, Science, vol.285, issue.5428, pp.727-729, 1999.
DOI : 10.1126/science.285.5428.727

M. Fogli, D. Mavilio, and E. Brunetta, Lysis of Endogenously Infected CD4+ T Cell Blasts by rIL-2 Activated Autologous Natural Killer Cells from HIV-Infected Viremic Individuals, PLoS Pathogens, vol.106, issue.7
DOI : 10.1371/journal.ppat.1000101.s005

D. Raulet, Roles of the NKG2D immunoreceptor and its ligands, Nature Reviews Immunology, vol.3, issue.10, pp.781-790, 2003.
DOI : 10.1038/nri1199

A. Barber and C. Sentman, NKG2D receptor regulates human effector T-cell cytokine production, Blood, vol.117, issue.24, pp.6571-6581, 2011.
DOI : 10.1182/blood-2011-01-329417

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123023

V. Groh, R. Rhinehart, and J. Randolph-habecker, Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells, Nature Immunology, vol.187, issue.3, pp.255-260, 2001.
DOI : 10.1038/85321

A. Jamieson, A. Diefenbach, and C. Mcmahon, The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing, Immunity, vol.17, issue.1, pp.19-29, 2002.
DOI : 10.1016/S1074-7613(02)00333-3

A. Zloza, F. Kohlhapp, and G. Lyons, NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses, Nature Medicine, vol.179, issue.3, pp.422-431, 2012.
DOI : 10.1128/CDLI.7.3.336-343.2000

P. Lang, K. Lang, and H. Xu, Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity, Proceedings of the National Academy of Sciences, vol.52, issue.1, pp.1210-1215, 2012.
DOI : 10.1038/nm1670

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268324

C. Cerboni, A. Zingoni, and M. Cippitelli, Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis, Blood, vol.110, issue.2, pp.606-615, 2007.
DOI : 10.1182/blood-2006-10-052720

V. Groh, J. Wu, C. Yee, and T. Spies, Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation, Nature, vol.17, issue.6908, pp.734-742, 2002.
DOI : 10.1126/science.285.5428.730

C. Cerboni, M. Ardolino, A. Santoni, and A. Zingoni, Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells, Blood, vol.113, issue.13, pp.2955-2964, 2009.
DOI : 10.1182/blood-2008-06-165944

M. Dalod, M. Dupuis, and J. Deschemin, Weak anti-HIV CD8+ T-cell effector activity in HIV primary infection, Journal of Clinical Investigation, vol.104, issue.10, pp.1431-1440, 1999.
DOI : 10.1172/JCI7162

F. Boufassa, A. Saez-cirion, and J. Lechenadec, CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory, PLoS ONE, vol.4, issue.9, p.18726, 2011.
DOI : 10.1371/journal.pone.0018726.t002

URL : https://hal.archives-ouvertes.fr/pasteur-01420582

P. Hunt, J. Brenchley, and E. Sinclair, T Cell Count in HIV???Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy, The Journal of Infectious Diseases, vol.197, issue.1, pp.126-133, 2008.
DOI : 10.1086/524143

D. Mavilio, J. Benjamin, and M. Daucher, Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates, Proceedings of the National Academy of Sciences, vol.170, issue.12, pp.15011-15017, 2003.
DOI : 10.4049/jimmunol.170.12.5965

H. Stephens, M. Mica, and . Genes, MICA and MICB genes: can the enigma of their polymorphism be resolved?, Trends in Immunology, vol.22, issue.7, pp.378-85, 2001.
DOI : 10.1016/S1471-4906(01)01960-3

C. Dalmasso, W. Carpentier, and L. Meyer, Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study, PLoS ONE, vol.46, issue.12, p.3907, 2008.
DOI : 10.1371/journal.pone.0003907.s002

V. Vieillard, H. Fausther-bovendo, and A. Samri, Specific Phenotypic and Functional Features of Natural Killer Cells From HIV-Infected Long-Term Nonprogressors and HIV Controllers, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.53, pp.564-73, 2010.
DOI : 10.1097/QAI.0b013e3181d0c5b4